These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28167655)

  • 1. Improving community access to terminal phase medicines through the implementation of a 'Core Medicines List' in South Australian community pharmacies.
    Tait P; Horwood C; Hakendorf P; To T
    BMJ Support Palliat Care; 2020 Mar; 10(1):e4. PubMed ID: 28167655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community pharmacists: a forgotten resource for palliative care.
    Tait PA; Gray J; Hakendorf P; Morris B; Currow DC; Rowett DS
    BMJ Support Palliat Care; 2013 Dec; 3(4):436-43. PubMed ID: 24950524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving community access to terminal phase medicines in Australia: identification of the key considerations for the implementation of a 'core medicines list'.
    Tait PA; Cheung WH; Wiese M; Staff K
    Aust J Prim Health; 2017 Sep; 23(4):373-378. PubMed ID: 28490412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Core palliative medicines: meeting the needs of non-complex community patients.
    Tait P; Morris B; To T
    Aust Fam Physician; 2014; 43(1):29-32. PubMed ID: 24563890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How timely is access to palliative care medicines in the community? A mixed methods study in a UK city.
    Miller EJ; Morgan JD; Blenkinsopp A
    BMJ Open; 2019 Nov; 9(11):e029016. PubMed ID: 31767580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cross-sectional survey of the access of older people in the Scottish Highlands to general medical practices, community pharmacies and prescription medicines.
    Rushworth GF; Cunningham S; Pfleger S; Hall J; Stewart D
    Res Social Adm Pharm; 2018 Jan; 14(1):76-85. PubMed ID: 28159532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards the implementation of breastfeeding-related health services in community pharmacies: Pharmacists' perspectives.
    Sim TF; Hattingh HL; Sherriff J; Tee LBG
    Res Social Adm Pharm; 2017; 13(5):980-988. PubMed ID: 28325528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of enhanced pharmacy services in rural community pharmacies in Western Australia.
    Wibowo Y; Berbatis C; Joyce A; Sunderland VB
    Rural Remote Health; 2010; 10(3):1400. PubMed ID: 20684656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A national survey exploring oral healthcare service provision across Australian community pharmacies.
    Freeman CR; Abdullah N; Ford PJ; Taing MW
    BMJ Open; 2017 Sep; 7(9):e017940. PubMed ID: 28963314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical networks influencing policy and practice: the establishment of advanced practice pharmacist roles for specialist palliative care services in South Australia.
    Swetenham K; Rowett D; Stephenson D
    Aust Health Rev; 2014 May; 38(2):238-41. PubMed ID: 24670916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs? Evidence from nine European countries.
    Vogler S; Habimana K; Arts D
    Health Policy; 2014 Sep; 117(3):311-27. PubMed ID: 24962537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a questionnaire to measure consumers' perceptions of service quality in community pharmacies.
    Mirzaei A; Carter SR; Chen JY; Rittsteuer C; Schneider CR
    Res Social Adm Pharm; 2019 Apr; 15(4):346-357. PubMed ID: 29903653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing purchase of and counselling about prescription and OTC medicines at community pharmacies in Tallinn, Estonia.
    Villako P; Volmer D; Raal A
    Acta Pol Pharm; 2012; 69(2):335-40. PubMed ID: 22568049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discounting of medicines in Australian community pharmacies.
    Thai LP; Vitry AI; Moss JR
    Aust Health Rev; 2014 Nov; 38(5):517-22. PubMed ID: 25099433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Service provision in the wake of a new funding model for community pharmacy.
    Smith AJ; Scahill SL; Harrison J; Carroll T; Medlicott NJ
    BMC Health Serv Res; 2018 May; 18(1):307. PubMed ID: 29716610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-prescription medicines: current issues in Australian community pharmacy.
    Tan AC; Emmerton L
    Int J Pharm Pract; 2009 Aug; 17(4):207-13. PubMed ID: 20217945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency, nature and determinants of pharmacy compounded medicines in Dutch community pharmacies.
    Buurma H; de Smet PA; van den Hoff OP; Sysling H; Storimans M; Egberts AC
    Pharm World Sci; 2003 Dec; 25(6):280-7. PubMed ID: 14689817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nurse practitioners: an insight into their integration into Australian community pharmacies.
    McMillan SS; Emmerton L
    Res Social Adm Pharm; 2013; 9(6):975-80. PubMed ID: 23062783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.